Crossmark

Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Crossref DOI link: https://doi.org/10.1007/s40744-020-00236-1

Published Online: 2020-09-29

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Askanase, Anca D.

Zhao, Enxu

Zhu, Julie

Bilyk, Roman

Furie, Richard A.
License Information

Text and Data Mining valid from 2020-09-29

Version of Record valid from 2020-09-29
More Information

Article History

Received: 30 July 2020

Accepted: 14 September 2020

First Online: 29 September 2020

Change Date: 30 August 2021

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s40744-021-00353-5

Updates are available Correction dated 2021-08-30

Click to view Correction: https://doi.org/10.1007/s40744-021-00353-5